InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Perry Matthew d. Director active across 3 companies, notably CTI Biopharma CORP. Aggregated, 4 reports have been published. History available since 26 June 2023. The latest transaction was disclosed on 21 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
PERRY MATTHEW D is a declarant and is a Director at XOMA Royalty Corp, XOMA Corp, and CTI Biopharma CORP. The record shows 4 filings in total, with sampled filings dated from 2023-06-26 to 2026-07-14, and the transaction nature is listed as Attribution.